Clinical trial
PET Imaging of Dopamine in Healthy Study Participants
NCT00062946 · National Institute of Mental Health (NIMH), NIH · Completed
Key facts
| NCT number | NCT00062946 |
|---|---|
| Title | PET Imaging of Dopamine in Healthy Study Participants |
| Official title | PET Imaging of Dopamine D2 Receptors and Extracellular Dopamine With (18F)Fallypride, D-amphetamine, and Alpha-Methyl-Para-Tyrosine in Healthy Subjects |
| Lead sponsor | National Institute of Mental Health (NIMH), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | (18F)fallypride |
| Enrollment | 45 |
| Start date | Jun 17, 2003 |
| Completion | Aug 15, 2007 |
| First posted | Jun 18, 2003 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: